Diligence memo · auto-generated · as of July 2, 2026
Hs Pharmaceuticals LLC
Hs Pharmaceuticals LLC looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Hs Pharmaceuticals LLC operates in Pharmaceuticals, based in GREENVILLE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Hs Pharmaceuticals LLC has raised $8.6M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $8.6M on 2008-03-17.
Most recent recorded round closed around 2008-03-17.
Valuation (modeled)modeled
Provath models Hs Pharmaceuticals LLC at approximately $265M (range $9.8M–$1.4B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.97× the median modeled value of Series A Pharmaceuticals companies in 2007–2009 (18 peers) — value vs value, same stage and era. Within the normal band (97% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 18.3 yr ago; this sector typically re-raises about every 13 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 51% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 73% of those peers.
Closest niche peers: Sinocom Pharmaceutical, Inc., Vitae Pharmaceuticals, Inc, QUATRX PHARMACEUTICALS Co, Qrxpharma Ltd, Elixir Pharmaceuticals, Inc..
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.